DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/b8b39b/future_nucleic_aci) has announced the addition of the "Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers" report to their offering.
This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.
Highlights
Business and technological trends in seven major markets Five- and ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product and business opportunities for instrument and consumable suppliers.Rationale
The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.
Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.
Worldwide Market Overview
Laboratories performing DNA sequencing and NAT by country and market segment. Ten-year test volume and sales projections by country.Market Segmentation Analysis
Sales and market shares of major suppliers of NAT reagent kits and components. Ten-year test volume and sales forecasts for major applications, including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Ten-year test volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing market, by country and laboratory segment, including: Industrial Academic Government Commercial Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.Product/Technology Review
Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers. Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including PCR bDNA SDA NASBA TMA SSSR, and others LCR Worldwide listings of companies, universities and research centers developing new NAT technologies and products.Competitive Assessments
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Comprehensive listings of companies developing and marketing NAT products, by test and application.Opportunities and Strategic Recommendations
Specific new product development opportunities with potentially significant market appeal during the next ten years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning issues and concerns.Contains 1050 pages and 96 tables
For more information visit http://www.researchandmarkets.com/research/b8b39b/future_nucleic_aci
